ID Nutra receives EFSA novel food application for satiety ingredient

By Will Chu

- Last updated on GMT


Related tags Obesity Fatty liver Metabolic syndrome

The European Food Safety Authority (EFSA) has granted a novel food application for the weight loss and metabolism management hoodia parviflora.

Now a non-endangered, safety validated specimen, H. parviflora​, has been approved as a Novel food for European community market as a whole-food ingredient.

“Since 2015, when this whole food ingredient of H. parviflora was accepted in Ireland, it has been under scrutiny in the EFSA Novel Food workgroup,”​ explained Iris Danieli, CEO of Desert Labs.

“It has been a long journey due to structural changes at EFSA, but finally we’re here.”

The decision follows a claim submitted to the authority’s register of questions in 2016, where US firm Desert Labs filed the application for the dried parts of H. parviflora​, that grow above the ground.

ID Nutra, the commercial partner for Desert Labs in the EU, has branded the concept SatiPlus, in which Karin Nielsen, vice president of ID Nutra described the ingredient as “100% natural and a whole-food – aligning perfectly with natural and clean label trends.”

“We expect to assist formulators in implementing SatiPlus in many innovative “anti-snacking” solutions for consumers; such as capsules, tablets, soft drinks, fortified sweeteners, nutrition bars, lozenges, gummies and chewing gums,“​ she said.

‘Opportunities for building a diverse usage’

The successes from US and Asia, as well as the convenient dosage of this active botanical adds to its purported qualities as an effective suppressor of thirst and hunger.

Its natural powder form contained in flavoured 3 gram (g) ice cubes or placebo cubes was given to 204 subjects during a 40-day study​, which resulted in a statistically significant loss of BMI, weight and waistline observed.  No adverse events were reported.

Desert Labs, which has self-affirmed Generally Recognised As Safe (GRAS) status in the US, launched ‘Snack Less’ gum in the US in 2012, with each piece containing 125 milligrams (mg) of the H. parviflora.

Since then the firm has been able to build up a body of evidence evaluating its safety with a number of published pre-clinical toxicological studies.

Results related to metabolic syndrome in a thirty-day study of persons with insulin resistance and non-alcoholic fatty liver disease demonstrated efficacy and no evidence of adverse events.

“The successes from US and Asia, as well as the convenient dosage of this active botanical, leaves opportunities for building a diverse usage,” ​added Nielsen.  

Related news

Show more

Related products

show more

New Study for Female Athletes

New Study for Female Athletes

Content provided by Gencor | 19-Oct-2023 | Product Brochure

In a recent clinical trial backing its ingredient Libifem® for improved muscle strength, power, endurance and body composition with a females-only popluation...

Custom Biotic Solutions for Digestive Health

Custom Biotic Solutions for Digestive Health

Content provided by ADM: Innovation that Feeds the Future | 10-Oct-2023 | White Paper

A growing body of evidence shows gut health can affect digestive health, well-being, and many health areas in between.

The Art of Organic Certification

The Art of Organic Certification

Content provided by FoodChain ID | 09-Oct-2023 | White Paper

The organic food market has experienced remarkable growth over the past decade, providing a major opportunity for food brands and manufacturers to tap...

An Insights-driven Holistic Approach to Health

An Insights-driven Holistic Approach to Health

Content provided by Lipofoods, a Lubrizol Company | 25-Sep-2023 | Product Brochure

As they adopt the notion of holistic health, proactive consumers are driving the demand for products that have science-backed ingredients and offer sensory...

Related suppliers

Follow us


View more